Rankings
Publications
Search Publications
Cited-by Search
Sources
Publishers
Scholars
Scholars
Top Cited Scholars
Organizations
About
Scilit
About Us
Advisory Board
Data Sources
Career
Support / Contact
User Guide
Publisher User
Search Function
Rankings Function
API Resource
Scilit Knowledge
Metrics
Scilit Recognitions
Publications Classification
Media
News
Blog
Login
Register
Home
Publications
Supplementary Information from MTHFD2 Enhances cMYC O-GlcNAcylation to Promote Sunitinib Resistance in Renal Cell Carcinoma
Home
Publications
Supplementary Information from MTHFD2 Enhances cMYC O-GlcNAcylation to Promote Sunitinib Resistance in Renal Cell Carcinoma
Supplementary Information from MTHFD2 Enhances cMYC O-GlcNAcylation to Promote Sunitinib Resistance in Renal Cell Carcinoma
Authors:
JL
Jinwen Liu
Jinwen Liu
GH
Gaowei Huang
Gaowei Huang
HL
Hao Lin
Hao Lin
RY
Rui Yang
Rui Yang
WZ
Wenhao Zhan
Wenhao Zhan
CL
Cheng Luo
Cheng Luo
YW
Yukun Wu
Yukun Wu
LC
Lingwu Chen
Lingwu Chen
XM
Xiaopeng Mao
Xiaopeng Mao
JC
Junxing Chen
Junxing Chen
BH
Bin Huang
Bin Huang
Article Alert
Citation Alert
Add to Library
Cite
Download
Share
Download
Open Access
Publisher website
Google Scholar
14 March 2025
other
Published by
American Association for Cancer Research (AACR)
DOI:
10.1158/0008-5472.28595162
Abstract
Figure S1-S17,Table S1-S2,Supplementary methods
Keywords
BIOLOGICAL AGENTS & THERAPIES
CELL-BASED THERAPEUTICS
DRUG RESISTANCE
CLINICAL DRUG RESISTANCE
NON-TRANSPORTER-BASED DRUG RESISTANCE
NOVEL MECHANISMS
GENITOURINARY CANCERS
RENAL CANCER
METABOLISM
METABOLIC PATHWAYS
Related articles
Scroll to top